作者：
Yu Jen,Jan [1]
;
Junhee,Yoon [2]
;
Jie-Fu,Chen [1]
;
Pai-Chi,Teng [1]
;
Nu,Yao [1]
;
Shirley,Cheng [1]
;
Amber,Lozano [1]
;
Gina C Y,Chu [1]
;
Howard,Chung [3]
;
Yi-Tsung,Lu [1]
;
Pin-Jung,Chen [3]
;
Jasmine J,Wang [3]
;
Yi-Te,Lee [3]
;
Minhyung,Kim [2]
;
Yazhen,Zhu [3]
;
Beatrice S,Knudsen [4]
;
Felix Y,Feng [5]
;
Isla P,Garraway [6]
;
Allen C,Gao [7]
;
Leland W K,Chung [8]
;
Michael R,Freeman [1]
;
Sungyong,You [2]
;
Hsian-Rong,Tseng [9]
;
Edwin M,Posadas [5]
作者单位：
Urologic Oncology Program and Uro-Oncology Research Laboratories, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[1]
Division of Cancer Biology and Therapeutics, Departments of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[2]
Department of Molecular and Medical Pharmacology, California NanoSystems Institute, Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, California, USA.
[3]
Translational Oncology Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[4]
Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[5]
Departments of Radiation Oncology, Urology, and Medicine, University of California, San Francisco, San Francisco, California, USA.
[6]
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
[7]
Department of Urology, University of California Davis, Davis, CA, USA.
[8]
Cancer Biology Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[9]
Division of Hematology/Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[10]
DOI
10.7150/thno.34485
PMID
31244925
发布时间
2020-05-25
换一批
换一批
